These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 32878036)

  • 1. Characterization of Competitive ELISA and Formulated Alhydrogel Competitive ELISA (FAcE) for Direct Quantification of Active Ingredients in GMMA-Based Vaccines.
    Rossi O; Aruta MG; Acquaviva A; Mancini F; Micoli F; Necchi F
    Methods Protoc; 2020 Aug; 3(3):. PubMed ID: 32878036
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of FAcE (Formulated Alhydrogel competitive ELISA) method for direct quantification of OAg present in Shigella sonnei GMMA-based vaccine and its optimization using Design of Experiments approach.
    Necchi F; Carducci M; Pisoni I; Rossi O; Saul A; Rondini S
    J Immunol Methods; 2019 Aug; 471():11-17. PubMed ID: 31039338
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Testing
    Mancini F; Caradonna V; Alfini R; Aruta MG; Vitali CG; Gasperini G; Piccioli D; Berlanda Scorza F; Rossi O; Micoli F
    Pharmaceutics; 2024 Apr; 16(4):. PubMed ID: 38675229
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Production of a Shigella sonnei Vaccine Based on Generalized Modules for Membrane Antigens (GMMA), 1790GAHB.
    Gerke C; Colucci AM; Giannelli C; Sanzone S; Vitali CG; Sollai L; Rossi O; Martin LB; Auerbach J; Di Cioccio V; Saul A
    PLoS One; 2015; 10(8):e0134478. PubMed ID: 26248044
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of
    Di Benedetto R; Mancini F; Caradonna V; Aruta MG; Giannelli C; Rossi O; Micoli F
    Front Mol Biosci; 2023; 10():1284515. PubMed ID: 38046812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GMMA and Glycoconjugate Approaches Compared in Mice for the Development of a Vaccine against
    Raso MM; Gasperini G; Alfini R; Schiavo F; Aruta MG; Carducci M; Forgione MC; Martini S; Cescutti P; Necchi F; Micoli F
    Vaccines (Basel); 2020 Apr; 8(2):. PubMed ID: 32260067
    [No Abstract]   [Full Text] [Related]  

  • 7. From an in vivo to an in vitro relative potency (IVRP) assay to fully characterize a multicomponent O-antigen based vaccine against Shigella.
    Necchi F; Giannelli C; Acquaviva A; Alfini R; Monaci V; Arato V; Rossi O; Micoli F
    Carbohydr Polym; 2023 Aug; 314():120920. PubMed ID: 37173008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dissecting the contribution of O-Antigen and proteins to the immunogenicity of Shigella sonnei generalized modules for membrane antigens (GMMA).
    Mancini F; Gasperini G; Rossi O; Aruta MG; Raso MM; Alfini R; Biagini M; Necchi F; Micoli F
    Sci Rep; 2021 Jan; 11(1):906. PubMed ID: 33441861
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative proteomic analysis of Shigella flexneri and Shigella sonnei Generalized Modules for Membrane Antigens (GMMA) reveals highly pure preparations.
    Maggiore L; Yu L; Omasits U; Rossi O; Dougan G; Thomson NR; Saul A; Choudhary JS; Gerke C
    Int J Med Microbiol; 2016 Feb; 306(2):99-108. PubMed ID: 26746581
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative immunogenicity and efficacy of equivalent outer membrane vesicle and glycoconjugate vaccines against nontyphoidal
    Micoli F; Rondini S; Alfini R; Lanzilao L; Necchi F; Negrea A; Rossi O; Brandt C; Clare S; Mastroeni P; Rappuoli R; Saul A; MacLennan CA
    Proc Natl Acad Sci U S A; 2018 Oct; 115(41):10428-10433. PubMed ID: 30262653
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety Profile and Immunologic Responses of a Novel Vaccine Against Shigella sonnei Administered Intramuscularly, Intradermally and Intranasally: Results From Two Parallel Randomized Phase 1 Clinical Studies in Healthy Adult Volunteers in Europe.
    Launay O; Lewis DJM; Anemona A; Loulergue P; Leahy J; Sciré AS; Maugard A; Marchetti E; Zancan S; Huo Z; Rondini S; Marhaba R; Finco O; Martin LB; Auerbach J; Cohen D; Saul A; Gerke C; Podda A
    EBioMedicine; 2017 Aug; 22():164-172. PubMed ID: 28735965
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exploring the Role of GMMA Components in the Immunogenicity of a 4-Valent Vaccine against
    Mancini F; Alfini R; Caradonna V; Monaci V; Carducci M; Gasperini G; Piccioli D; Biagini M; Giannelli C; Rossi O; Pizza M; Micoli F
    Int J Mol Sci; 2023 Feb; 24(3):. PubMed ID: 36769063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of O-Antigen Chain Length Regulation on the Immunogenicity of
    Gasperini G; Raso MM; Arato V; Aruta MG; Cescutti P; Necchi F; Micoli F
    Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33525644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of O-antigen delivered by Generalized Modules for Membrane Antigens (GMMA) vaccine candidates against nontyphoidal Salmonella.
    De Benedetto G; Alfini R; Cescutti P; Caboni M; Lanzilao L; Necchi F; Saul A; MacLennan CA; Rondini S; Micoli F
    Vaccine; 2017 Jan; 35(3):419-426. PubMed ID: 27998639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of endotoxicity of Shigella generalized modules for membrane antigens (GMMA) by genetic lipid A modifications: relative activation of TLR4 and TLR2 pathways in different mutants.
    Rossi O; Pesce I; Giannelli C; Aprea S; Caboni M; Citiulo F; Valentini S; Ferlenghi I; MacLennan CA; D'Oro U; Saul A; Gerke C
    J Biol Chem; 2014 Sep; 289(36):24922-35. PubMed ID: 25023285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A next-generation GMMA-based vaccine candidate to fight shigellosis.
    Rossi O; Citiulo F; Giannelli C; Cappelletti E; Gasperini G; Mancini F; Acquaviva A; Raso MM; Sollai L; Alfini R; Aruta MG; Vitali CG; Pizza M; Necchi F; Rappuoli R; Martin LB; Berlanda Scorza F; Colucci AM; Micoli F
    NPJ Vaccines; 2023 Sep; 8(1):130. PubMed ID: 37670042
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    Necchi F; Stefanetti G; Alfini R; Palmieri E; Carducci M; Di Benedetto R; Schiavo F; Aruta MG; Giusti F; Ferlenghi I; Goh YS; Rondini S; Micoli F
    Pathogens; 2021 Jun; 10(6):. PubMed ID: 34207575
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Hanumunthadu B; Kanji N; Owino N; Ferreira Da Silva C; Robinson H; White R; Ferruzzi P; Nakakana U; Canals R; Pollard AJ; Ramasamy M;
    BMJ Open; 2023 Nov; 13(11):e072938. PubMed ID: 37963701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapid generation of Shigella flexneri GMMA displaying natural or new and cross-reactive O-Antigens.
    Gasperini G; Raso MM; Schiavo F; Aruta MG; Ravenscroft N; Bellich B; Cescutti P; Necchi F; Rappuoli R; Micoli F
    NPJ Vaccines; 2022 Jun; 7(1):69. PubMed ID: 35773292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simplified low-cost production of O-antigen from Salmonella Typhimurium Generalized Modules for Membrane Antigens (GMMA).
    Meloni E; Colucci AM; Micoli F; Sollai L; Gavini M; Saul A; Di Cioccio V; MacLennan CA
    J Biotechnol; 2015 Mar; 198():46-52. PubMed ID: 25659926
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.